In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe, effective and affordable vaccine.
According to BCM, Hyderabad-headquartered BE has licensed the recombinant protein COVID-19 vaccine candidate developed at Baylor.
In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe, effective and affordable vaccine.
According to BCM, Hyderabad-headquartered BE has licenced the recombinant protein COVID-19 vaccine candidate developed at Baylor
.
